Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
12,349.47
-46.80
(-0.38%)
NZD/USD
0.5890
+0.0001
(+0.01%)
NZD/EUR
0.5417
-0.0009
(-0.16%)
ALL ORDS
8,153.40
+59.10
(+0.73%)
ASX 200
7,921.30
+60.10
(+0.76%)
OIL
76.44
-1.84
(-2.35%)
10x Genomics, Inc. (TXG)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.22
+0.30
(+1.51%)
At close: 04:00PM EDT
20.23
+0.01
(+0.05%)
After hours:
07:56PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
625,448
618,727
516,409
490,490
298,845
Cost of revenue
221,611
209,414
120,386
74,091
58,468
Gross profit
403,837
409,313
396,023
416,399
240,377
Operating expenses
Research development
332,852
331,312
265,667
211,752
570,923
Selling general and administrative
345,824
343,330
298,300
257,560
202,326
Total operating expenses
678,676
674,642
563,967
469,312
773,249
Operating income or loss
-274,839
-265,329
-167,944
-52,913
-532,872
Interest expense
15
33
476
866
1,682
Total other income/expenses net
169
-307
-198
-142
-1,454
Income before tax
-256,912
-248,763
-161,971
-53,715
-534,476
Income tax expense
7,389
6,336
4,029
4,508
8,255
Income from continuing operations
-264,301
-255,099
-166,000
-58,223
-542,731
Net income
-264,301
-255,099
-166,000
-58,223
-542,731
Net income available to common shareholders
-264,301
-255,099
-166,000
-58,223
-542,731
Basic EPS
-1.46
-2.18
-1.46
-0.53
-5.37
Diluted EPS
-1.46
-2.18
-1.46
-0.53
-5.37
Basic average shares
113,859
117,165
113,859
110,348
101,152
Diluted average shares
113,859
117,165
113,859
110,348
101,152
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.